DOJ Targets Telehealth Fraud Tied To Genetic Testing

Law360 (September 25, 2019, 7:41 PM EDT) -- The U.S. Department of Justice is taking aim at alleged telehealth schemes that fraudulently billed hundreds of millions of dollars to Medicare for genetic testing and other treatments, court documents showed on Wednesday.

Federal prosecutors in Florida charged Minal Patel, CEO of genetic testing company LabSolutions, with paying kickbacks to others who provided patient referrals. The scheme saw Medicare pay more than $164 million for gene testing aimed at detecting a patient’s risk of developing cancer, according to the indictment unsealed on Wednesday.

Multiple cases filed in Georgia on Tuesday also referred to a nationwide telehealth scheme, variously described as having participants...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS